Testosterone therapy masculinizes speech and gender presentation in transgender men

Abstract Voice is one of the most noticeably dimorphic traits in humans and plays a central role in gender presentation. Transgender males seeking to align internal identity and external gender expression frequently undergo testosterone (T) therapy to masculinize their voices and other traits. We ai...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Carolyn R. Hodges-Simeon, Graham P. O. Grail, Graham Albert, Matti D. Groll, Cara E. Stepp, Justin M. Carré, Steven A. Arnocky
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/cef9f2ee96b1483080cb37b9d29ff97d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cef9f2ee96b1483080cb37b9d29ff97d
record_format	dspace
spelling	oai:doaj.org-article:cef9f2ee96b1483080cb37b9d29ff97d2021-12-02T14:26:55ZTestosterone therapy masculinizes speech and gender presentation in transgender men10.1038/s41598-021-82134-22045-2322https://doaj.org/article/cef9f2ee96b1483080cb37b9d29ff97d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82134-2https://doaj.org/toc/2045-2322Abstract Voice is one of the most noticeably dimorphic traits in humans and plays a central role in gender presentation. Transgender males seeking to align internal identity and external gender expression frequently undergo testosterone (T) therapy to masculinize their voices and other traits. We aimed to determine the importance of changes in vocal masculinity for transgender men and to determine the effectiveness of T therapy at masculinizing three speech parameters: fundamental frequency (i.e., pitch) mean and variation (f o and f o-SD) and estimated vocal tract length (VTL) derived from formant frequencies. Thirty transgender men aged 20 to 40 rated their satisfaction with traits prior to and after T therapy and contributed speech samples and salivary T. Similar-aged cisgender men and women contributed speech samples for comparison. We show that transmen viewed voice change as critical to transition success compared to other masculine traits. However, T therapy may not be sufficient to fully masculinize speech: while f o and f o-SD were largely indistinguishable from cismen, VTL was intermediate between cismen and ciswomen. f o was correlated with salivary T, and VTL associated with T therapy duration. This argues for additional approaches, such as behavior therapy and/or longer duration of hormone therapy, to improve speech transition.Carolyn R. Hodges-SimeonGraham P. O. GrailGraham AlbertMatti D. GrollCara E. SteppJustin M. CarréSteven A. ArnockyNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Carolyn R. Hodges-Simeon Graham P. O. Grail Graham Albert Matti D. Groll Cara E. Stepp Justin M. Carré Steven A. Arnocky Testosterone therapy masculinizes speech and gender presentation in transgender men
description	Abstract Voice is one of the most noticeably dimorphic traits in humans and plays a central role in gender presentation. Transgender males seeking to align internal identity and external gender expression frequently undergo testosterone (T) therapy to masculinize their voices and other traits. We aimed to determine the importance of changes in vocal masculinity for transgender men and to determine the effectiveness of T therapy at masculinizing three speech parameters: fundamental frequency (i.e., pitch) mean and variation (f o and f o-SD) and estimated vocal tract length (VTL) derived from formant frequencies. Thirty transgender men aged 20 to 40 rated their satisfaction with traits prior to and after T therapy and contributed speech samples and salivary T. Similar-aged cisgender men and women contributed speech samples for comparison. We show that transmen viewed voice change as critical to transition success compared to other masculine traits. However, T therapy may not be sufficient to fully masculinize speech: while f o and f o-SD were largely indistinguishable from cismen, VTL was intermediate between cismen and ciswomen. f o was correlated with salivary T, and VTL associated with T therapy duration. This argues for additional approaches, such as behavior therapy and/or longer duration of hormone therapy, to improve speech transition.
format	article
author	Carolyn R. Hodges-Simeon Graham P. O. Grail Graham Albert Matti D. Groll Cara E. Stepp Justin M. Carré Steven A. Arnocky
author_facet	Carolyn R. Hodges-Simeon Graham P. O. Grail Graham Albert Matti D. Groll Cara E. Stepp Justin M. Carré Steven A. Arnocky
author_sort	Carolyn R. Hodges-Simeon
title	Testosterone therapy masculinizes speech and gender presentation in transgender men
title_short	Testosterone therapy masculinizes speech and gender presentation in transgender men
title_full	Testosterone therapy masculinizes speech and gender presentation in transgender men
title_fullStr	Testosterone therapy masculinizes speech and gender presentation in transgender men
title_full_unstemmed	Testosterone therapy masculinizes speech and gender presentation in transgender men
title_sort	testosterone therapy masculinizes speech and gender presentation in transgender men
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/cef9f2ee96b1483080cb37b9d29ff97d
work_keys_str_mv	AT carolynrhodgessimeon testosteronetherapymasculinizesspeechandgenderpresentationintransgendermen AT grahampograil testosteronetherapymasculinizesspeechandgenderpresentationintransgendermen AT grahamalbert testosteronetherapymasculinizesspeechandgenderpresentationintransgendermen AT mattidgroll testosteronetherapymasculinizesspeechandgenderpresentationintransgendermen AT caraestepp testosteronetherapymasculinizesspeechandgenderpresentationintransgendermen AT justinmcarre testosteronetherapymasculinizesspeechandgenderpresentationintransgendermen AT stevenaarnocky testosteronetherapymasculinizesspeechandgenderpresentationintransgendermen
_version_	1718391338968285184

Testosterone therapy masculinizes speech and gender presentation in transgender men

Ejemplares similares